O18 Topline safety and efficacy data analysis of phase 1/2 clinical trial evaluating AOC 1001 in adults with myotonic dystrophy type 1: MARINA TM

N. Johnson,J. Day,J. Hamel, C. Thornton, S. Subramony, P. Soltanzadeh,J. Statland,M. Wicklund,W. Arnold,M. Freimer, K. DiTrapani, C. Heusner, C. Chen, B. McEvoy, Y. Zhu, L. Tai, E. Ackermann

Neuromuscular Disorders(2023)

引用 0|浏览3
暂无评分
关键词
myotonic dystrophy type,clinical trial,efficacy data analysis,aoc
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要